Do clinical guidelines facilitate or impede drivers of treatment in Fabry disease?

BACKGROUND: Variable disease progression confounds accurate prognosis in Fabry disease. Evidence supports the long-term benefit of early intervention with disease-specific therapy, but current guidelines recommend treatment initiation based on signs that may present too late to avoid irreversible or...

Descripción completa

Detalles Bibliográficos
Autores principales: Hughes, Derralynn A., Aguiar, Patrício, Lidove, Olivier, Nicholls, Kathleen, Nowak, Albina, Thomas, Mark, Torra, Roser, Vujkovac, Bojan, West, Michael L., Feriozzi, Sandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822651/
https://www.ncbi.nlm.nih.gov/pubmed/35135579
http://dx.doi.org/10.1186/s13023-022-02181-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822651/
https://www.ncbi.nlm.nih.gov/pubmed/35135579
http://dx.doi.org/10.1186/s13023-022-02181-4

Ejemplares similares